Authorised gene therapy Hemgenix (etranacogene dezaparvovec) for Hemophilia B with conditional approval by EMA.
Hemophilia B
20-year archive
FDA · EMA · ClinicalTrials.gov
500,233+ documents
Track every FDA, EMA, and trial event for your disease.
20 years of regulatory and clinical-trial documents, AI-tagged by indication. Browse free or get email alerts when something new lands for the conditions you follow.
500,233
documents analyzed
33,066
diseases
87,177
drugs tracked
What's new this week
Browse all →Voranigo (vorasidenib) from Les Laboratoires Servier has been authorised by the EMA for certain gliomas, including oligodendroglioma and astrocytoma, and has orphan medicine status.
Astrocytoma, Oligodendroglioma
Tecvayli has been authorised by the EMA for multiple myeloma.
Multiple Myeloma
EMA authorised Blenrep (belantamab mafodotin) for multiple myeloma, with GSK as the marketing authorisation holder.
Multiple Myeloma
EMA Authorised status for Comirnaty (BioNTech) for COVID-19 infection; authorised as a vaccine with mRNA encoding the SARS-CoV-2 spike protein.
The EMA has authorised Spikevax (Moderna) for use in the EU; it is an mRNA vaccine encoding the SARS-CoV-2 spike protein for COVID-19.
COVID-19 Disease
Browse by disease
33052 diseases · top 60 shown- Breast Cancer11,438
- Type 2 Diabetes Mellitus9,496
- Obesity7,837
- Major Depressive Disorder7,079
- Non-small Cell Lung Cancer6,855
- HIV Infection6,454
- Hypertension6,385
- Stroke6,087
- Colorectal Cancer5,300
- Prostate Cancer5,166
- Heart Failure4,746
- Coronary Artery Disease4,532
- Chronic Obstructive Pulmonary Disease4,318
- Asthma4,271
- Cancer3,981
- Schizophrenia3,863
- Parkinson Disease3,527
- Chronic Kidney Disease3,434
- Diabetes Mellitus3,426
- Multiple Myeloma3,175
- Pain3,167
- Rheumatoid Arthritis3,153
- Alzheimer Disease3,122
- Type 1 Diabetes Mellitus3,116
- Acute Myeloid Leukemia3,020
- Epilepsy2,861
- Hepatocellular Carcinoma2,830
- Atrial Fibrillation2,747
- Pancreatic Cancer2,594
- Ovarian Cancer2,509
- Gastric Cancer2,480
- Multiple Sclerosis2,405
- Bipolar Disorder2,362
- Cardiovascular Disease2,335
- Lung Cancer2,230
- Melanoma2,197
- Hepatitis C2,147
- Infertility2,132
- Anxiety Disorders2,072
- Myocardial Infarction2,060
- Attention Deficit Hyperactivity Disorder2,012
- End-stage Renal Disease1,983
- Low Back Pain1,837
- Osteoarthritis1,802
- Postoperative Pain1,780
- Crohn Disease1,735
- Ulcerative Colitis1,734
- Migraine1,725
- Cervical Cancer1,717
- Cognitive Impairment1,699
- Head and Neck Cancer1,680
- Non-hodgkin Lymphoma1,662
- Post-traumatic Stress Disorder1,644
- Acute Lymphoblastic Leukemia1,618
- Opioid Use Disorder1,607
- Autism Spectrum Disorder1,602
- Obstructive Sleep Apnea1,590
- Hepatitis B1,548
- Renal Cell Carcinoma1,540
- Atopic Dermatitis1,529
Why people use Catalyst Wire
Patients & caregivers
Subscribe to email alerts for your disease. Get a weekly digest of new approvals, trial readouts, and label changes — written in plain language so you can come prepared to your next appointment.
Investors & analysts
Importance-scored feed across FDA, EMA, and ClinicalTrials.gov. Drug timelines, JSON API, and category filters built for due diligence — not last-week news.
Clinicians
One disease page per indication, with every recent regulatory action and trial readout in one place. Cited links to the original FDA/EMA documents for verification.
Simple pricing
Free for browsing. Pay if you want alerts, drug timelines, or API access.
Free
$0 /forever
For occasional browsing
- All disease pages
- Document titles, dates, sources
- 1-line summaries
- Search
- Daily newsletter (opt-in)
- Email alerts
- Drug timelines
- Importance scores
Plus
$9 /month
For people following a condition
- Everything in Free
- Email alerts for any disease
- Daily or weekly digests
- Drug timelines
- Full LLM summaries
- Importance scores
- Manufacturer & indication data
- JSON API at full rate
Pro
$99 /month
For investors, analysts, clinicians
- Everything in Plus
- Raw metadata access
- JSON API at full rate
- 500 results per page
- All categories visible
- Webhook alerts (coming)
- Priority support